We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.56B
AUM Growth
-$38.5M
Cap. Flow
-$387M
Cap. Flow %
-24.76%
Top 10 Hldgs %
13.79%
Holding
357
New
58
Increased
94
Reduced
104
Closed
53

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$15.9M
2
AVGO icon
Broadcom
AVGO
+$7.71M
3
FCAM
Fiat Chrysler Automobiles N.V.
FCAM
+$7.55M
4
VC icon
Visteon
VC
+$6.62M
5
MGM icon
MGM Resorts International
MGM
+$6.53M

Top Sells

Rank Stock Value
1
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$13.6M
2
VEEV icon
Veeva Systems
VEEV
+$9.49M
3
ALL icon
Allstate
ALL
+$9.41M
4
PAY
Verifone Systems Inc
PAY
+$8.26M
5
URI icon
United Rentals
URI
+$6.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.11%
2 Healthcare 12.19%
3 Technology 11.28%
4 Financials 9.06%
5 Industrials 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RENT
201
DELISTED
RENTRAK CORP
RENT
$2.38M 0.15%
+34,083
New +$2.06M
ZSPH
202
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$2.37M 0.15%
45,300
-39,443
-47% -$1.94M
WWD icon
203
Woodward
WWD
$22B
$2.34M 0.15%
42,557
-12,542
-23% -$643K
EOG icon
204
EOG Resources
EOG
$71.5B
$2.27M 0.15%
25,901
+4,025
+18% +$372K
XPO icon
205
XPO
XPO
$23.4B
$2.27M 0.15%
145,102
-115,280
-44% -$1.87M
ONCE
206
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.26M 0.14%
37,540
+20,856
+125% +$1.38M
VSTO
207
DELISTED
Vista Outdoor Inc.
VSTO
$2.25M 0.14%
50,174
+7,797
+18% +$351K
WFT
208
DELISTED
Weatherford International plc
WFT
$2.25M 0.14%
183,300
-8,759
-5% -$122K
ALDR
209
DELISTED
Alder Biopharmaceuticals
ALDR
$2.24M 0.14%
42,255
-13,508
-24% -$491K
GS icon
210
Goldman Sachs
GS
$313B
$2.23M 0.14%
10,681
+1,660
+18% +$338K
SCHW
211
Charles Schwab
SCHW
$188B
$2.22M 0.14%
67,881
+10,549
+18% +$333K
LDRH
212
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$2.21M 0.14%
51,147
-16,409
-24% -$652K
SHOO icon
213
Steven Madden
SHOO
$3.59B
$2.19M 0.14%
76,667
-24,580
-24% -$648K
PTLA
214
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.17M 0.14%
47,557
-15,184
-24% -$611K
CSTE icon
215
Caesarstone
CSTE
$80.2M
$2.08M 0.13%
+30,395
New +$1.88M
NKE icon
216
Nike
NKE
$63B
$2.07M 0.13%
38,250
+5,944
+18% +$305K
PLKI
217
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$2.04M 0.13%
34,049
-22,150
-39% -$1.28M
OREX
218
DELISTED
Orexigen Therapeutics, Inc.
OREX
$2.03M 0.13%
40,941
-13,142
-24% -$786K
TA
219
DELISTED
TravelCenters of America LLC
TA
$2M 0.13%
26,941
-8,635
-24% -$692K
DVAX
220
DELISTED
Dynavax Technologies
DVAX
$2M 0.13%
+85,185
New +$1.86M
KTWO
221
DELISTED
K2M Group Holdings, Inc
KTWO
$1.99M 0.13%
+82,688
New +$1.97M
SSE
222
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
$1.94M 0.12%
452,389
-454,709
-50% -$2.4M
GMED icon
223
Globus Medical
GMED
$10.9B
$1.93M 0.12%
75,182
-24,131
-24% -$611K
KITE
224
DELISTED
Kite Pharma, Inc.
KITE
$1.91M 0.12%
+31,354
New +$1.79M
TXMD icon
225
TherapeuticsMD
TXMD
$24M
$1.91M 0.12%
4,852
-1,559
-24% -$550K
7 8
9
10 11

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Nicholas Investment Partners held 357 positions worth $1.56B, down 2.4% from $1.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Nicholas Investment Partners withdrew a net $387M in Q2 2015, closing 53 positions and reducing 104 holdings. Its most notable exit was ACTAVIS PLC Pfd Conv Ser A (Irl), an estimated $13.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nicholas Investment Partners opened a new position in Allergan plc worth $15.9M.

  • Nicholas Investment Partners's largest Q2 2015 buy was Allergan plc: 15,220 shares worth $15.9M.
  • Nicholas Investment Partners added most to Visteon in Q2 2015, an estimated $6.62M increase.
  • Nicholas Investment Partners's biggest Q2 2015 reduction was Illumina, cutting an estimated $6.06M.
  • Nicholas Investment Partners fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $13.6M.
  • Nicholas Investment Partners's ten largest holdings make up 14% of its $1.56B portfolio in Q2 2015.
  • Nicholas Investment Partners opened 58 new positions and closed 53 in Q2 2015.
  • Nicholas Investment Partners's portfolio value fell 2.4% quarter-over-quarter to $1.56B.

Based on Nicholas Investment Partners's 13F filing for Q2 2015, filed 17 Aug 2015.